Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Jones Trading Initiates Coverage On CervoMed with Buy Rating, Announces Price Target of $70

Author: Benzinga Newsdesk | May 29, 2024 06:38am
Jones Trading analyst Soumit Roy initiates coverage on CervoMed (NASDAQ:CRVO) with a Buy rating and announces Price Target of $70.

Posted In: CRVO